一名接受泊沙康唑治疗的患者出现男性乳腺增生和高血压。
Gynecomastia and hypertension in a patient treated with posaconazole.
作者信息
Thompson George R, Surampudi Prasanth N, Odermatt Alex
机构信息
Department of Internal Medicine Division of Infectious Diseases University of California Davis Medical Center Davis CA USA.
Department of Internal Medicine Division of Endocrinology University of California Davis Medical Center Davis CA USA.
出版信息
Clin Case Rep. 2020 Sep 28;8(12):3158-3161. doi: 10.1002/ccr3.3376. eCollection 2020 Dec.
Abstract
Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.
摘要
泊沙康唑治疗可能导致血清雌二醇水平升高和男性乳腺增生。通过内分泌激素检测进行早期发现可能有助于预防男性乳腺增生。
相似文献
1
Gynecomastia and hypertension in a patient treated with posaconazole.一名接受泊沙康唑治疗的患者出现男性乳腺增生和高血压。
Clin Case Rep. 2020 Sep 28;8(12):3158-3161. doi: 10.1002/ccr3.3376. eCollection 2020 Dec.
2
Posaconazole-induced hypertension and hypokalemia due to inhibition of the 11β-hydroxylase enzyme.泊沙康唑因抑制11β-羟化酶而导致高血压和低钾血症。
Clin Kidney J. 2018 Oct;11(5):691-693. doi: 10.1093/ckj/sfx156. Epub 2018 Jan 30.
3
Posaconazole-Induced Hypertension Due to Inhibition of 11-Hydroxylase and 11-Hydroxysteroid Dehydrogenase 2.泊沙康唑因抑制11β-羟化酶和11β-羟类固醇脱氢酶2而导致高血压。
J Endocr Soc. 2019 Jun 6;3(7):1361-1366. doi: 10.1210/js.2019-00189. eCollection 2019 Jul 1.
4
Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.泊沙康唑和伊曲康唑诱导的假性醛固酮增多症的分子机制，以及其他系统使用的唑类抗真菌药物的评估。
J Steroid Biochem Mol Biol. 2020 May;199:105605. doi: 10.1016/j.jsbmb.2020.105605. Epub 2020 Jan 23.
5
Mineralocorticoid hypertension and hypokalaemia induced by posaconazole.泊沙康唑引起的盐皮质激素性高血压和低钾血症
Endocrinol Diabetes Metab Case Rep. 2018 Feb 9;2018. doi: 10.1530/EDM-17-0157. eCollection 2018.
6
Unravelling drug-induced hypertension: molecular mechanisms of aldosterone-independent mineralocorticoid receptor activation by posaconazole.解析药物性高血压：泊沙康唑非醛固酮依赖性激活盐皮质激素受体的分子机制
Clin Kidney J. 2018 Oct;11(5):688-690. doi: 10.1093/ckj/sfy087. Epub 2018 Sep 20.
7
11β-Hydroxysteroid Dehydrogenase Inhibition in Posaconazole-Induced Hypertension and Hypokalemia.泊沙康唑诱导的高血压和低钾血症中11β-羟基类固醇脱氢酶的抑制作用
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00760-17. Print 2017 Aug.
8
Posaconazole-Induced Hypertension Masquerading as Congenital Adrenal Hyperplasia in a Child with Cystic Fibrosis.泊沙康唑诱发的高血压在一名囊性纤维化儿童中伪装成先天性肾上腺皮质增生症。
Case Rep Med. 2020 Aug 28;2020:8153012. doi: 10.1155/2020/8153012. eCollection 2020.
9
Pathophysiology of spironolactone-induced gynecomastia.螺内酯所致男性乳房发育症的病理生理学
Ann Intern Med. 1977 Oct;87(4):398-403. doi: 10.7326/0003-4819-87-4-398.
10
Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.伊曲康唑和泊沙康唑对11β-羟类固醇脱氢酶2抑制作用的种属特异性差异。
Toxicol Appl Pharmacol. 2021 Feb 1;412:115387. doi: 10.1016/j.taap.2020.115387. Epub 2020 Dec 31.
引用本文的文献
1
Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids.评估奥替康唑和其他两种四氮唑类抗真菌药抑制肾上腺类固醇生成及皮质类固醇外周代谢的潜在风险。
Front Pharmacol. 2024 Aug 8;15:1394846. doi: 10.3389/fphar.2024.1394846. eCollection 2024.
2
Characterization of the interferences of systemic azole antifungal drugs with adrenal steroid biosynthesis using H295R cells and enzyme activity assays.利用H295R细胞和酶活性测定法对全身性唑类抗真菌药物干扰肾上腺类固醇生物合成的特性进行研究。
Curr Res Toxicol. 2023 Aug 14;5:100119. doi: 10.1016/j.crtox.2023.100119. eCollection 2023.
3
Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.唑类抗真菌药物治疗诱导获得性表观盐皮质激素过多症：文献和数据库分析。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0166821. doi: 10.1128/AAC.01668-21. Epub 2021 Oct 18.
本文引用的文献
1
Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.泊沙康唑和伊曲康唑诱导的假性醛固酮增多症的分子机制，以及其他系统使用的唑类抗真菌药物的评估。
J Steroid Biochem Mol Biol. 2020 May;199:105605. doi: 10.1016/j.jsbmb.2020.105605. Epub 2020 Jan 23.
2
Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism.泊沙康唑血药浓度与假性醛固酮增多症相关。
Clin Infect Dis. 2020 Jun 10;70(12):2593-2598. doi: 10.1093/cid/ciz741.
3
Posaconazole-Induced Hypertension Due to Inhibition of 11-Hydroxylase and 11-Hydroxysteroid Dehydrogenase 2.泊沙康唑因抑制11β-羟化酶和11β-羟类固醇脱氢酶2而导致高血压。
J Endocr Soc. 2019 Jun 6;3(7):1361-1366. doi: 10.1210/js.2019-00189. eCollection 2019 Jul 1.
4
Drug-induced endocrine blood pressure elevation.药物引起的内分泌性血压升高。
Pharmacol Res. 2020 Apr;154:104311. doi: 10.1016/j.phrs.2019.104311. Epub 2019 Jun 15.
5
Posaconazole-induced hypertension and hypokalemia due to inhibition of the 11β-hydroxylase enzyme.泊沙康唑因抑制11β-羟化酶而导致高血压和低钾血症。
Clin Kidney J. 2018 Oct;11(5):691-693. doi: 10.1093/ckj/sfx156. Epub 2018 Jan 30.
6
Mineralocorticoid hypertension and hypokalaemia induced by posaconazole.泊沙康唑引起的盐皮质激素性高血压和低钾血症
Endocrinol Diabetes Metab Case Rep. 2018 Feb 9;2018. doi: 10.1530/EDM-17-0157. eCollection 2018.
7
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors.高选择性、广谱真菌CYP51抑制剂的设计与优化
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3243-3248. doi: 10.1016/j.bmcl.2017.06.037. Epub 2017 Jun 15.
8
11β-Hydroxysteroid Dehydrogenase Inhibition in Posaconazole-Induced Hypertension and Hypokalemia.泊沙康唑诱导的高血压和低钾血症中11β-羟基类固醇脱氢酶的抑制作用
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00760-17. Print 2017 Aug.
9
Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.从泊沙康唑混悬液换用片剂可提高白血病患者的血清药物水平，且无临床相关肝毒性。
Antimicrob Agents Chemother. 2014 Nov;58(11):6993-5. doi: 10.1128/AAC.04035-14. Epub 2014 Sep 8.
10
Drug-induced gynecomastia.药物引起的男子女性型乳房。
Pharmacotherapy. 2012 Dec;32(12):1123-40. doi: 10.1002/phar.1138. Epub 2012 Nov 16.
Zotero 插件